Keywords: فیبریلاسیون دهلیزی غیر واگیری; Cardioembolic stroke; dabigatran; idarucizumab; nonvalvular atrial fibrillation; recombinant tissue plasminogen activator;
مقالات ISI فیبریلاسیون دهلیزی غیر واگیری (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Acute ischemic stroke; anticoagulants; nonvalvular atrial fibrillation; secondary prevention;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Direct oral anticoagulants; apixaban; nonvalvular atrial fibrillation; appropriate dose; recurrence of ischemic stroke; inappropriate low dose;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; AF; atrial fibrillation; ARISTOTLE(âJ); Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (âJapanese patients); AVERROES; Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Cardiogenic thromboembolism; Left atrial appendage; Nonvalvular atrial fibrillation; Stapler; Thoracoscopic surgery;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Obstrucción venosa retiniana; Factores de riesgo vascular; Fibrilación auricular no valvular; Anticoagulación; Retinal vein occlusion; Cardiovascular risk factors; Nonvalvular atrial fibrillation; Anticoagulation;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Retinal vein occlusion; Cardiovascular risk factors; Nonvalvular atrial fibrillation; Anticoagulation; Obstrucción venosa retiniana; Factores de riesgo vascular; Fibrilación auricular no valvular; Anticoagulación;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Smoking; Transesophageal echocardiography; Nonvalvular atrial fibrillation;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Fibrilación auricular no valvular; Práctica clÃnica; Pacientes de la vida real; Rivaroxaban; ROCKET-AF; Registro; Nonvalvular atrial fibrillation; Clinical practice; Real-life patients; Rivaroxaban; ROCKET-AF; Registry;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; ABN; abnormality; AP; anteroposterior; AF; atrial fibrillation; 2P; biplane; BMI; body mass index; BSA; body surface area; DM; diabetes mellitus; EF; ejection fraction; GFR; glomerular filtration rate; HTN; hypertension; ICD; implantable cardioverter defi
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Direct oral anticoagulants; DOACs; Nonvalvular atrial fibrillation; Postmarketing studies; Safety;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Atrial fibrillation; Diastolic function; Left atrial appendage thrombus; Spontaneous echocardiographic contrast; Echocardiography; AUC; Area under the curve; LA; Left atrial; LAA; Left atrial appendage; LVEF; Left ventricular ejection fraction; NVAF; Nonv
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Left atrial appendage; Nonvalvular atrial fibrillation; Occlusion; Stroke;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; direct thrombin inhibitor; factor Xa inhibitor; hemorrhage; mortality; warfarin; AF; atrial fibrillation; AMI; acute myocardial infarction; ASMD; absolute standardized mean difference; CI; confidence interval; CKD; chronic kidney disease; GI; gastrointest
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Smoking; Prognosis
Keywords: فیبریلاسیون دهلیزی غیر واگیری; AF; atrial fibrillation; CHADS2; Congestive heart failure, Hypertension, Age >75 years, Diabetes mellitus, and Stroke/transient ischemic attack; INR; international normalized ratio; LAAT; left atrium appendage thrombus; NVAF; nonvalvular atrial fibrillati
Keywords: فیبریلاسیون دهلیزی غیر واگیری; CHF; congestive heart failure; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75 years (doubled), diabetes mellitus, stroke (doubled)-vascular disease, age 65 to 74 years, and sex category (female); EKG; electrocardiography; H/H; HEPES-buf
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Edoxaban; warfarin; nonvalvular atrial fibrillation; stroke; systemic embolism; bleeding;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Elderly; Nonvalvular atrial fibrillation; Guidelines; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban; EdoxabanAnciano; Fibrilación auricular no valvular; Guías; Antagonistas de la vitamina K; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Anciano; Fibrilación auricular no valvular; Guías; Antagonistas de la vitamina K; Dabigatran; Rivaroxaban; Apixaban; EdoxabanElderly; Nonvalvular atrial fibrillation; Guidelines; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban; Edoxaban
Keywords: فیبریلاسیون دهلیزی غیر واگیری; apixaban; cost-effectiveness; nonvalvular atrial fibrillation; Japan;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; cost; cost of illness; India; nonvalvular atrial fibrillation; stroke;
Keywords: فیبریلاسیون دهلیزی غیر واگیری; left atrial appendage occlusion; nonvalvular atrial fibrillation; stroke prevention; Watchman deviceAF, atrial fibrillation; CI, confidence interval; INR, international normalized ratio(s); LAA, left atrial appendage; NOAC, novel oral anticoagulant; RR, r
Keywords: فیبریلاسیون دهلیزی غیر واگیری; closure devices; left atrial appendage occlusion; nonvalvular atrial fibrillation; stroke; systematic analysisAF, atrial fibrillation; CHADS2, congestive heart failure, hypertension, age >75 years, diabetes mellitus, and prior stroke or transient ischemic
Keywords: فیبریلاسیون دهلیزی غیر واگیری; AF; atrial fibrillation; ATRIA; Anticoagulation and Risk Factors in Atrial Fibrillation; CHADS2; congestive heart failure, hypertension, age ⥠75 years, diabetes, prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive heart failure, hyperte
Keywords: فیبریلاسیون دهلیزی غیر واگیری; ACP; Amplatzer Cardiac Plug; AF; atrial fibrillation; ASA; aspirin; DPI; dual platelet inhibition; LA; left atrium/atrial; LAA; left atrial appendage; NVAF; nonvalvular atrial fibrillation; OAC; oral anticoagulation; PROTECT-AF; Percutaneous Closure of th
Postapproval Community Hospital Experience in the United States with Left Atrial Appendage Closure Device (Watchman)
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; left atrial appendage closure device; Watchman device; stroke prevention; community hospital;
The Amplatzer Amulet Device
Keywords: فیبریلاسیون دهلیزی غیر واگیری; AMPLATZER Amulet; Left atrial appendage occlusion; Nonvalvular atrial fibrillation; Transseptal puncture; Chicken wing anatomy;
Low Body Mass Index is a Poor Prognosis Factor in Cardioembolic Stroke Patients with NonValvular Atrial Fibrillation
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Low body mass index; nonvalvular atrial fibrillation; cardioembolic stroke; stroke severity; functional outcome;
Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury
Keywords: فیبریلاسیون دهلیزی غیر واگیری; atrial fibrillation; drug-induced liver injury; oral anticoagulants; population-based; CI; confidence interval; HR; hazard ratio; ICD-10-CA; International Classification of Diseases-10th Revision, for Canada; ISQ; Institut de la statistique du Québec; ME
CHADS2 and modified CHA2DS2-VASc scores for the prediction of congestive heart failure in patients with nonvalvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Congestive heart failure; Mortality; CHADS2 score; Modified CHA2DS2-VASc score;
Monitoring of anti-Xa activity and factors related to bleeding events: A study in Japanese patients with nonvalvular atrial fibrillation receiving rivaroxaban
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Factor Xa inhibitor; Nonvalvular atrial fibrillation; Coagulation test; Bleeding complication;
Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Rivaroxaban; Nonvalvular atrial fibrillation; Stroke; Hemorrhage; China;
Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay
Keywords: فیبریلاسیون دهلیزی غیر واگیری; AE; Adverse events; aPTT; activated partial thromboplastin time; ANOVA; Analysis of variance; CI; Confidence interval; DOACs; Direct oral anticoagulants; FDA; Food and Drug Administration; FXa; Factor Xa; GLSM; Geometric least squares means; LC/MS/MS; Liq
Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation
Keywords: فیبریلاسیون دهلیزی غیر واگیری; atrial fibrillation; LAmbre; left atrial appendage closure; stroke; AF; atrial fibrillation; CHADS2; congestive heart failure, hypertension, age â¥75 years, diabetes mellitus, and prior stroke or transient ischemic attack; CHA2DS2-VASc; congestive he
Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study)
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Antiplatelet; Cross-sectional study; Nonvalvular atrial fibrillation; Oral anticoagulant;
Recursos y necesidades asistenciales en el tratamiento anticoagulante de los pacientes con fibrilación auricular no valvular. Estudio SAMOA
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Tratamiento anticoagulante; Fibrilación auricular no valvular; Proceso asistencial; Prevención secundaria; Accidente cerebrovascular; Hemorragia; Anticoagulant therapy; Nonvalvular atrial fibrillation; Healthcare process; Secondary prevention; Stroke; H
Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA Study
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Anticoagulant therapy; Nonvalvular atrial fibrillation; Healthcare process; Secondary prevention; Stroke; Hemorrhage; Tratamiento anticoagulante; Fibrilación auricular no valvular; Proceso asistencial; Prevención secundaria; Accidente cerebrovascular; H
Uso de los anticoagulantes orales de acción directa en atención primaria: Estudio ACTUA
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Antagonistas de la vitamina K; Anticoagulación; Anticoagulantes orales de acción directa; Fibrilación auricular no valvular; Método Delphi; Vitamin K antagonists; Anticoagulation; Direct oral anticoagulants; Nonvalvular atrial fibrillation; Delphi pro
Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study
Keywords: فیبریلاسیون دهلیزی غیر واگیری; VKA; Vitamin K antagonist; NOAC; Non-vitamin K antagonist oral anticoagulant; PCC; Prothrombin complex concentrate; SAMURAI; The Stroke Acute Management with Urgent Risk-factor Assessment and Improvement; NVAF; Nonvalvular atrial fibrillation; TIA; Transi
Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; rivaroxaban; secondary prevention; design;
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Antiarrhythmic therapy; Cardioversion; Ablation; FANTASIIA registry; Fibrilación auricular no valvular; Tratamiento antiarrÃtmico; Cardioversión; Ablación; Registro FANTASIIA; AF; atrial fibrillation; HF; heart failure
Estudios en fase III del edoxabán
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Edoxabán; Ensayos en fase III; Eficacia; Seguridad; Fibrilación auricular no valvular; Enfermedad tromboembólica venosa; Ictus; Edoxaban; Phase-III studies; Efficacy; Safety; Nonvalvular atrial fibrillation; Venous thromboembolism; Stroke;
Association of Soluble CD40 Ligand With Duration of Atrial Fibrillation and With Intensity of Spontaneous Echocardiographic Contrast
Keywords: فیبریلاسیون دهلیزی غیر واگیری; atrial fibrillation; left atrial appendage thrombus; sCD40L levels; AUC; area under the curve; CD40L; CD40 ligand; CHA2DS2-VASc; congestive heart failure, hypertension, age â¥75years, diabetes mellitus, stroke/transient ischemic attack, vascular disease,
Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Oral anticoagulants; Vitamin K antagonists; Rosendaal methodFibrilación auricular no valvular; Anticoagulantes orales; Antagonistas de la vitamina K; Método de RosendaalINR, international normalized ratio; NVAF, nonvalvula
Assessment of Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Primary Health Care in Galicia, Spain: ANFAGAL Study
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Anticoagulation; Primary health care; Fibrilación auricular no valvular; Anticoagulación; Atención primaria; AF; atrial fibrillation; TTR; time in therapeutic range; VKA; vitamin K antagonist;
Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Coronary artery disease; Incidence; Prognosis;
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL Trial
Keywords: فیبریلاسیون دهلیزی غیر واگیری; atrial fibrillation; left atrial appendage; stroke prevention; LAA; left atrial appendage; NOACs; new oral anticoagulants; NVAF; nonvalvular atrial fibrillation; SE; systemic embolism; TEE; transesophageal echocardiography;
Device- and LAA-Specific Characteristics for Successful LAA Closure
Keywords: فیبریلاسیون دهلیزی غیر واگیری; Nonvalvular atrial fibrillation; Ischemic embolic strokes; Transcatheter left atrial appendage occlusion;
Thoracoscopic Stand-Alone Left Atrial Appendectomy for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation
Keywords: فیبریلاسیون دهلیزی غیر واگیری; left atrial appendage excision; nonvalvular atrial fibrillation; secondary prevention stroke; thromboembolism; AF; atrial fibrillation; LA; left atrium; LAA; left atrial appendage; TEE; transesophageal echocardiography;